Tempest Therapeutics tempesttx.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Tempest Therapeutics, fka Inception 2 and fka Next Beta, is a development stage biotechnology company that is focused on small molecule therapeutics that modulate anti-tumor immunity pathways.

Tempest Therapeutics, fka Inception 2 and fka Next Beta, is a development stage biotechnology company that is focused on small molecule therapeutics that modulate anti-tumor immunity pathways.

Company (Alive / Active)

Phone:

Fax:

One Sansome Street
Suite 3690
San Francisco, 94104
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Tempest Therapeutics $75M Mar 1, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Tempest Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Pyrazolone compounds and uses thereof Feb 09, 2015 Jan 09, 2018 Patent
Triazolone compounds and uses thereof Sep 04, 2014 Oct 03, 2017 Patent
Triazolone compounds and uses thereof Dec 10, 2013 Jun 13, 2017 Patent
Triazolone compounds and uses thereof Mar 07, 2013 Nov 29, 2016 Patent
Pyrazolone compounds and uses thereof Dec 01, 2017 Application
See all 6 patents